Clinical Trials Browser

Phase 2 × regorafenib × Tumor-Agnostic × Clear all

NCT04116541 2025-11-21

MegaMOST

Phase 2 Recruiting

Neoplasm Metastasis

NCT01929616 2019-06-25

RegARd-C

Phase 2 Completed

Adenocarcinoma